Nexalin Technology (NXL) Shares Outstanding (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Shares Outstanding (Entity) of $20.6 million for Q1 2026, up 54.42% year-over-year from $13.3 million in Q1 2025, and up 7.27% quarter-over-quarter from $19.2 million in Q4 2025.
Nexalin Technology (NXL) Shares Outstanding (2021 - 2026) Analysis & Trends
Nexalin Technology's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $20.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 54.42% year-over-year to $20.6 million; the TTM figure through Mar 2026 stood at $20.6 million (up 54.42% YoY), while the FY2025 annual figure was $19.2 million, up 108.19% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $20.6 million, up from $19.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $20.6 million in Q1 2026, with the low at $4.9 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $7.4 million (2023), against an average of $10.3 million.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) rose 2.06% in 2024, then surged 129.59% in 2025.
- Nexalin Technology's Shares Outstanding (Entity) stood at $5.6 million in 2022, then jumped by 33.45% to $7.4 million in 2023, then grew by 23.93% to $9.2 million in 2024, then soared by 108.19% to $19.2 million in 2025, then gained by 7.27% to $20.6 million in 2026.
- Business Quant data shows NXL's Shares Outstanding (Entity) at $20.6 million in Q1 2026, $19.2 million in Q4 2025, and $18.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 21.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.82 Mn |
| Mar 31, 2026 | 19.82 Mn |
| Dec 31, 2025 | 16.39 Mn |
| Sep 30, 2025 | 17.79 Mn |
| Jun 30, 2025 | 15.72 Mn |
| Mar 31, 2025 | 13.31 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Sep 30, 2024 | 10.85 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 7.44 Mn |
| Dec 31, 2023 | 7.36 Mn |
| Sep 30, 2023 | 7.42 Mn |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 4.42 Mn |